Monday, 13th April 2026
Monday, 13th April 2026
Breaking News :
DMP Busts Major Mobile Smuggling Network in Dhaka Raid Joint Operation Seizes 48,500 Litres Oil “DMCH Clash Inquiry Panel Begins Urgent Investigation” “Illegal Octane Stock Seized in Chattogram Raid” “Dhaka Medical Clash Over Unavailable Emergency Injections” Eight More Flights Cancelled Amid Gulf Disruption Manager Arrested Over 50,000-Litre Fuel Discrepancy Mirza Abbas’s Health Shows Signs of Improvement DMP Busts Major Mobile Smuggling Network in Dhaka Raid Joint Operation Seizes 48,500 Litres Oil “DMCH Clash Inquiry Panel Begins Urgent Investigation” “Illegal Octane Stock Seized in Chattogram Raid” “Dhaka Medical Clash Over Unavailable Emergency Injections” Eight More Flights Cancelled Amid Gulf Disruption Manager Arrested Over 50,000-Litre Fuel Discrepancy Mirza Abbas’s Health Shows Signs of Improvement DMP Busts Major Mobile Smuggling Network in Dhaka Raid Joint Operation Seizes 48,500 Litres Oil “DMCH Clash Inquiry Panel Begins Urgent Investigation” “Illegal Octane Stock Seized in Chattogram Raid” “Dhaka Medical Clash Over Unavailable Emergency Injections” Eight More Flights Cancelled Amid Gulf Disruption Manager Arrested Over 50,000-Litre Fuel Discrepancy Mirza Abbas’s Health Shows Signs of Improvement DMP Busts Major Mobile Smuggling Network in Dhaka Raid Joint Operation Seizes 48,500 Litres Oil “DMCH Clash Inquiry Panel Begins Urgent Investigation” “Illegal Octane Stock Seized in Chattogram Raid” “Dhaka Medical Clash Over Unavailable Emergency Injections” Eight More Flights Cancelled Amid Gulf Disruption Manager Arrested Over 50,000-Litre Fuel Discrepancy Mirza Abbas’s Health Shows Signs of Improvement DMP Busts Major Mobile Smuggling Network in Dhaka Raid Joint Operation Seizes 48,500 Litres Oil “DMCH Clash Inquiry Panel Begins Urgent Investigation” “Illegal Octane Stock Seized in Chattogram Raid” “Dhaka Medical Clash Over Unavailable Emergency Injections” Eight More Flights Cancelled Amid Gulf Disruption Manager Arrested Over 50,000-Litre Fuel Discrepancy Mirza Abbas’s Health Shows Signs of Improvement DMP Busts Major Mobile Smuggling Network in Dhaka Raid Joint Operation Seizes 48,500 Litres Oil “DMCH Clash Inquiry Panel Begins Urgent Investigation” “Illegal Octane Stock Seized in Chattogram Raid” “Dhaka Medical Clash Over Unavailable Emergency Injections” Eight More Flights Cancelled Amid Gulf Disruption Manager Arrested Over 50,000-Litre Fuel Discrepancy Mirza Abbas’s Health Shows Signs of Improvement DMP Busts Major Mobile Smuggling Network in Dhaka Raid Joint Operation Seizes 48,500 Litres Oil “DMCH Clash Inquiry Panel Begins Urgent Investigation” “Illegal Octane Stock Seized in Chattogram Raid” “Dhaka Medical Clash Over Unavailable Emergency Injections” Eight More Flights Cancelled Amid Gulf Disruption Manager Arrested Over 50,000-Litre Fuel Discrepancy Mirza Abbas’s Health Shows Signs of Improvement DMP Busts Major Mobile Smuggling Network in Dhaka Raid Joint Operation Seizes 48,500 Litres Oil “DMCH Clash Inquiry Panel Begins Urgent Investigation” “Illegal Octane Stock Seized in Chattogram Raid” “Dhaka Medical Clash Over Unavailable Emergency Injections” Eight More Flights Cancelled Amid Gulf Disruption Manager Arrested Over 50,000-Litre Fuel Discrepancy Mirza Abbas’s Health Shows Signs of Improvement DMP Busts Major Mobile Smuggling Network in Dhaka Raid Joint Operation Seizes 48,500 Litres Oil “DMCH Clash Inquiry Panel Begins Urgent Investigation” “Illegal Octane Stock Seized in Chattogram Raid” “Dhaka Medical Clash Over Unavailable Emergency Injections” Eight More Flights Cancelled Amid Gulf Disruption Manager Arrested Over 50,000-Litre Fuel Discrepancy Mirza Abbas’s Health Shows Signs of Improvement DMP Busts Major Mobile Smuggling Network in Dhaka Raid Joint Operation Seizes 48,500 Litres Oil “DMCH Clash Inquiry Panel Begins Urgent Investigation” “Illegal Octane Stock Seized in Chattogram Raid” “Dhaka Medical Clash Over Unavailable Emergency Injections” Eight More Flights Cancelled Amid Gulf Disruption Manager Arrested Over 50,000-Litre Fuel Discrepancy Mirza Abbas’s Health Shows Signs of Improvement

Business

Kyobo Life Profit Rises Despite Weak Core Earnings

Khabor Wala Desk

Published: 13th April 2026, 4:58 PM

Kyobo Life Profit Rises Despite Weak Core Earnings

South Korea’s Kyobo Life Insurance reported a notable rebound in net profit for the 2025 financial year, even as its core insurance business showed signs of strain. The insurer posted a net profit of $0.5 billion (KRW763.2 billion), marking a 9.2% year-on-year increase and reversing the decline observed earlier in the year.

However, the improvement was largely driven by non-operational factors rather than fundamental business strength. In particular, a sharp reduction in associate impairment losses played a decisive role in lifting overall profitability. These losses fell significantly to $0.1 billion (KRW119 billion) in 2025, compared with $0.2 billion (KRW279 billion) the previous year, providing a substantial boost to the bottom line.

Core Insurance Business Under Pressure

Despite the rise in net profit, Kyobo Life’s core insurance performance weakened considerably. Insurance profit for the year declined by 17.3% to $0.3 billion (KRW391.6 billion), reflecting mounting cost pressures and less favourable actuarial developments.

Although service income increased by 8.4%, this gain was more than offset by a sharp rise in insurance service expenses, which climbed 11.8% to reach $2.7 billion (KRW4.0 trillion). The widening gap between income and expenses underscores the challenges facing the insurer’s core operations.

Two key factors contributed to the deterioration:

  • Recognition of onerous contracts, where expected future costs exceed anticipated revenues.
  • Adverse changes in actuarial assumptions, which raised the projected liabilities associated with policyholder obligations.

These elements highlight the sensitivity of life insurers to shifts in long-term assumptions such as mortality rates, policyholder behaviour, and discount rates.

Investment Performance Stagnates

Kyobo Life’s investment segment offered little support to overall earnings growth. Investment profit remained broadly flat at $0.5 billion (KRW670.0 billion), as increases in investment income were largely offset by rising expenses.

This stagnation reflects a challenging investment environment, where insurers must balance the need for yield generation against market volatility and regulatory constraints. With interest rates and asset valuations fluctuating, maintaining stable investment returns has become increasingly complex.

Financial Overview

A summary of Kyobo Life’s key financial indicators is presented below:

Metric 2025 შედეგ 2024 Result Change (%)
Net Profit $0.5b $0.46b +9.2%
Insurance Profit $0.3b $0.47b -17.3%
Investment Profit $0.5b $0.5b ~0%
Associate Impairment Losses $0.1b $0.2b -~57%
Insurance Service Expenses $2.7b $2.4b +11.8%

Outlook: Key Risks and Watchpoints

According to CreditSights, Kyobo Life’s future performance will depend heavily on several critical factors.

First, the stability of actuarial assumptions will be closely monitored. Any further adverse revisions could exert additional pressure on insurance profitability and capital adequacy.

Second, the performance of associate subsidiaries will remain a key variable. Given the significant impact of impairment losses on recent results, fluctuations in the valuation of these investments could materially affect earnings.

Finally, regulatory developments will play an important role. In particular, the gradual withdrawal of regulatory relief measures for lapse risks—introduced to cushion insurers against policy cancellations—may create additional headwinds if not carefully managed.

A Profit Rebound with Underlying Fragility

While Kyobo Life’s headline profit growth presents a positive narrative, the underlying picture is more complex. The reliance on reduced impairment losses rather than stronger operational performance raises questions about the sustainability of earnings growth.

As cost pressures mount and regulatory conditions evolve, the insurer faces a delicate balancing act: strengthening its core insurance operations whilst maintaining stable investment returns. The coming years will be critical in determining whether Kyobo Life can translate short-term gains into durable, long-term profitability.

Comments